홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Olmutinib

HCID 54758501
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1353550-13-6
표준 SMILES
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1
InChIKey
FDMQDKQUTRLUBU-UHFFFAOYSA-N
분자식
C26H26N6O2S
평균 분자량
486.6 g/mol
단동위원소 질량
486.18379527

개요

Olmutinib is an orally active epidermal growth factor receptor inhibitor used in the treatment of T790M mutation positive non-small cell lung cancer. It is available under the brand name Olita made by Hanmi Pharmaceuticals. Olmutinib was developed by Hanmi Pharmaceuticals and Boehringer Ingelheim. Olmutinib recieved breakthrough therapy designation in the United States in December 2015 and was approved for use in Korea in May 2016.

이름 및 식별자

우선 이름
Olmutinib
IUPAC
N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide
영어명
HM-61713 (BI-1482694)
분자량
0

이름 및 동의어

Olmutinib1353550-13-6BI 1482694HM-61713N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamideBI-1482694CHL9B67L952-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-DTXSID0013191192-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamideN-(3-((2-(4-(4-Methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide
이름 더 보기
HM-61713 (BI-1482694)NSC 163501ANTIBIOTIC AT-125U 42126HM 61713BI1482694
N-[3-({2-[4-(4-Methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl}oxy)phenyl]prop-2-enamideolmutinibumN-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamideN-(3-(2-(4-(4-methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxyphenyl)prop-2-enamideRefChem:856756L01XE40DTXCID401748550HM61713

데이터베이스 식별자

CAS
1353550-13-6、1802181-20-9
PubChem CID
54758501
DTXSID
DTXSID001319119
ChEMBL
CHEMBL3786343
UNII
CHL9B67L95
Nikkaji
J3.435.413H

물성

구조 계산 물성보충 중

XLogP
4.7
극성 표면적
111 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
8
회전 가능 결합 수
7
무거운 원자 수
35
형식 전하
0
복잡도
712

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15

화학 및 산업

약리 정보

ATC Code · 2건

L - Antineoplastic and immunomodulating agents

QL - Antineoplastic and immunomodulating agents

Protein BindingData not yet available.
Pharmacodynamics · 1건

Olmutinib selectively and irreversibly binds and inhibits epidermal growth factor receptors (EGFR) with the T790M activating mutation. EGFRs are frequently over-expressed in lung cancer and contribute to activation of the phosphoinositide 3-kinase and mitogen activated protein kinase pathways which both promote cell survival and proliferation. By inhibiting EGFR activation, olmutinib attenuates the activation of these tumor promoting pathways.

Mechanism of Action · 1건

Olmutinib covalently binds a cysteine residue near the kinase domain of mutant EGFRs to prevent phosphorylation of the receptor. This inhibits receptor signalling as phosphorylation is necessary for recruitment of signalling cascade proteins.

Biological Half-Life8-11h.
Metabolism/MetabolitesData not yet available.
Absorption, Distribution and Excretion · 4건

tmax of 3-4h with oral administration.

Data not yet available.

Data not yet available.

Data not yet available.

관련 반응

3건
반응 기록 만들기
HRID 526057 반응식
HRID 526057생성물로
HRID 1850015 반응식
HRID 1850015반응물로
HRID 1850016 반응식
HRID 1850016생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트